In vitro fluorescence polarization assay
AssigneeARIAD Pharmaceuticals, Inc.
InventorsBerkley A. Lynch, Ian MacNeil, Mark Zoller
Life of this patent
Estimating the term…
Loading patent…
AssigneeARIAD Pharmaceuticals, Inc.
InventorsBerkley A. Lynch, Ian MacNeil, Mark Zoller
Estimating the term…
An in vitro assay method permits the identification of a test substance which inhibits the mutual association of two molecules. The method includes the steps of providing two components capable of mutual association, one of said components bearing a covalently linked fluorophore; preparing a mixture containing the two components and at least one test substance; irradiating the mixture with polarized light of a suitable wavelength permitting excitation of the fluorophore as indicated by emission of polarized light; measuring the degree of polarization of the emission, and determining the effect of the presence or concentration of the test substance in decreasing the observed emission polarization of a mixture of the two components alone. Inhibitory activity of the test substance correlates with decreased depolarization values.
An in vitro assay method for identifying a test substance which inhibits the mutual association of two molecules, said method comprising:
An in vitro assay method for identifying a test substance which competitively binds to either a receptor tyrosine-phosphorylated peptide and/or its ligand, said method comprising:
An in vitro assay method for identifying a test substance which inhibits the mutual association of two protein molecules, said method comprising:
Dependencies are inferred from the claim text.